Verve Therapeutics Statistics
Total Valuation
CELH has a market cap or net worth of $11.54 billion. The enterprise value is $10.58 billion.
| Market Cap | 11.54B |
| Enterprise Value | 10.58B |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025, before market open.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CELH has 257.95 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 257.95M |
| Shares Outstanding | 257.95M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | -8.03% |
| Owned by Insiders (%) | 10.85% |
| Owned by Institutions (%) | 65.86% |
| Float | 189.95M |
Valuation Ratios
The trailing PE ratio is 137.67 and the forward PE ratio is 48.47. CELH's PEG ratio is 1.84.
| PE Ratio | 137.67 |
| Forward PE | 48.47 |
| PS Ratio | 7.88 |
| Forward PS | 4.55 |
| PB Ratio | 23.75 |
| P/TBV Ratio | 32.17 |
| P/FCF Ratio | 56.05 |
| P/OCF Ratio | 49.80 |
| PEG Ratio | 1.84 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 74.01, with an EV/FCF ratio of 51.40.
| EV / Earnings | 137.32 |
| EV / Sales | 7.96 |
| EV / EBITDA | 74.01 |
| EV / EBIT | 78.78 |
| EV / FCF | 51.40 |
Financial Position
The company has a current ratio of 3.38, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.38 |
| Quick Ratio | 2.95 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.10 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.19% and return on invested capital (ROIC) is 6.84%.
| Return on Equity (ROE) | 9.19% |
| Return on Assets (ROA) | 4.79% |
| Return on Invested Capital (ROIC) | 6.84% |
| Return on Capital Employed (ROCE) | 9.31% |
| Revenue Per Employee | $1.24M |
| Profits Per Employee | $71,789 |
| Employee Count | 1,073 |
| Asset Turnover | 0.76 |
| Inventory Turnover | 3.89 |
Taxes
In the past 12 months, CELH has paid $51.90 million in taxes.
| Income Tax | 51.90M |
| Effective Tax Rate | 31.73% |
Stock Price Statistics
The stock price has decreased by -4.51% in the last 52 weeks. The beta is 1.40, so CELH's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | -4.51% |
| 50-Day Moving Average | 43.14 |
| 200-Day Moving Average | 33.46 |
| Relative Strength Index (RSI) | 48.60 |
| Average Volume (20 Days) | 4,456,544 |
Short Selling Information
The latest short interest is 21.46 million, so 8.32% of the outstanding shares have been sold short.
| Short Interest | 21.46M |
| Short Previous Month | 24.89M |
| Short % of Shares Out | 8.32% |
| Short % of Float | 11.30% |
| Short Ratio (days to cover) | 3.63 |
Income Statement
In the last 12 months, CELH had revenue of $1.33 billion and earned $77.03 million in profits. Earnings per share was $0.32.
| Revenue | 1.33B |
| Gross Profit | 670.37M |
| Operating Income | 134.27M |
| Pretax Income | n/a |
| Net Income | 77.03M |
| EBITDA | 142.93M |
| EBIT | 134.27M |
| Earnings Per Share (EPS) | $0.32 |
Balance Sheet
The company has $977.29 million in cash and $19.70 million in debt, giving a net cash position of $957.58 million or $3.71 per share.
| Cash & Cash Equivalents | 977.29M |
| Total Debt | 19.70M |
| Net Cash | 957.58M |
| Net Cash Per Share | $3.71 |
| Equity (Book Value) | 1.27B |
| Book Value Per Share | 1.88 |
| Working Capital | 993.60M |
Cash Flow
In the last 12 months, operating cash flow was $231.62 million and capital expenditures -$25.81 million, giving a free cash flow of $205.81 million.
| Operating Cash Flow | 231.62M |
| Capital Expenditures | -25.81M |
| Free Cash Flow | 205.81M |
| FCF Per Share | $0.80 |
Margins
Gross margin is 50.43%, with operating and profit margins of 10.10% and 8.40%.
| Gross Margin | 50.43% |
| Operating Margin | 10.10% |
| Pretax Margin | 12.31% |
| Profit Margin | 8.40% |
| EBITDA Margin | 10.75% |
| EBIT Margin | 10.10% |
| FCF Margin | 15.48% |
Dividends & Yields
CELH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | -0.02% |
| Earnings Yield | 0.67% |
| FCF Yield | 1.78% |
Analyst Forecast
The average price target for CELH is $48.71, which is 8.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $48.71 |
| Price Target Difference | 8.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 20.49% |
| EPS Growth Forecast (5Y) | 30.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 15, 2023. It was a forward split with a ratio of 3:1.
| Last Split Date | Nov 15, 2023 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
CELH has an Altman Z-Score of 12.06 and a Piotroski F-Score of 5.
| Altman Z-Score | 12.06 |
| Piotroski F-Score | 5 |